Abstract
AbstractAlthough the rapid spread of antimicrobial resistance (AMR), particularly in relation to clinical settings, is causing concern in many regions of the globe, remote, extreme environments, such as Antarctica, are thought to be relatively free from the negative impact of human activities. In fact, Antarctica is often perceived as the last pristine continent on Earth. Such remote regions, which are assumed to have very low levels of AMR due to limited human activity, represent potential model environments to understand the mechanisms and interactions underpinning the early stages of evolution, de novo development, acquisition and transmission of AMR. Antarctica, with its defined zones of human colonisation (centred around scientific research stations) and large populations of migratory birds and animals, also has great potential with regard to mapping and understanding the spread of early-stage zoonotic interactions. However, to date, studies of AMR in Antarctica are limited. Here, we survey the current literature focussing on the following:
Dissection of human-introduced AMR versus naturally occurring AMR, based on the premise that multiple drug resistance and resistance to synthetic antibiotics not yet found in nature are the results of human contamination
The potential role of endemic wildlife in AMR spread
There is clear evidence for greater concentrations of AMR around research stations, and although data show reverse zoonosis of the characteristic human gut bacteria to endemic wildlife, AMR within birds and seals appears to be very low, albeit on limited samplings. Furthermore, areas where there is little, to no, human activity still appear to be free from anthropogenically introduced AMR. However, a comprehensive assessment of AMR levels in Antarctica is virtually impossible on current data due to the wide variation in reporting standards and methodologies used and poor geographical coverage. Thus, future studies should engage directly with policymakers to promote the implementation of continent-wide AMR reporting standards. The development of such standards alongside a centralised reporting system would provide baseline data to feedback directly into wastewater treatment policies for the Antarctic Treaty Area to help preserve this relatively pristine environment.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology
Reference86 articles.
1. White A, Hughes JM. Critical importance of a One Health approach to antimicrobial resistance. Ecohealth. 2019;16(3):404–9.
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: Government of the United Kingdom; 2016.
3. Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, et al. Antimicrobial resistance and COVID-19: intersections and implications. Elife. 2021;10:e64139.
4. World Health Organization (WHO). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: early implementation 2020. Geneva: WHO Press; 2020.
5. Sriram A, Kalanxhi E, Kapoor G, Craig J, Balasubramanian R, Brar S, et al. State of the world’s antibiotics 2021: a global analysis of antimicrobial resistance and its drivers. Washington DC: Center for Disease Dynamics, Economics & Policy; 2021.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献